BD Rhapsody Onco-BC 乳癌靶向檢測(cè)試劑盒（panel）

英文名稱：BD Rhapsody™  Onco-BC Targeted Panel

中文名稱：BD Rhapsody Onco-BC 乳癌靶向檢測(cè)試劑盒（panel）

用途：與BD Rhapsody單細(xì)胞表達(dá)分析儀配合使用，檢測(cè)與乳腺癌和免疫細(xì)胞相關(guān)的 400 個(gè)基因

乳腺癌生物學(xué)因復(fù)雜的基因表達(dá)，細(xì)胞異質(zhì)性和患者間的差異而變得復(fù)雜。為了解決這一復(fù)雜性，BD Rhapsody™OncoBC靶向檢測(cè)panel使用BD Rhapsody單細(xì)胞分析系統(tǒng)為單細(xì)胞乳腺癌研究提供了一種簡(jiǎn)化的檢測(cè)方法。 通過集中分析與乳腺癌生物學(xué)zui相關(guān)的基因和標(biāo)志物，減少測(cè)序通量，并且降低了與整個(gè)轉(zhuǎn)錄組測(cè)序相關(guān)時(shí)間和測(cè)序成本。

BD Rhapsody™  Onco-BC Targeted Panel特點(diǎn)

經(jīng)驗(yàn)證的基因panel專注于人類乳腺癌生物學(xué)

有針對(duì)性的方法提高了實(shí)驗(yàn)效率

可重復(fù)的檢測(cè)方法可用于各種實(shí)驗(yàn)

歡迎您咨詢華雅再生醫(yī)學(xué)旗艦公司：紅榮微再（上海）生物工程技術(shù)有限公司  ：1500 1904 520。紅榮微再-客服:  經(jīng)銷商專員

BD Rhapsody單細(xì)胞分析系統(tǒng)

BD Rhapsody單細(xì)胞分析系統(tǒng)是一種新型的單細(xì)胞mRNA表達(dá)分析儀器。它能捕獲并分離細(xì)胞，通過磁珠對(duì)細(xì)胞和mRNA轉(zhuǎn)錄本進(jìn)行分類擴(kuò)增以供測(cè)序。作為單細(xì)胞RNA-seq的新方法，與傳統(tǒng)的全轉(zhuǎn)錄組擴(kuò)增（WTA）相比，BD Rhapsody單細(xì)胞分析系統(tǒng)可以同時(shí)處理12個(gè)樣本，能夠?qū)Τ汕先f個(gè)單細(xì)胞的數(shù)百個(gè)表達(dá)基因進(jìn)行數(shù)字定量，極大程度節(jié)省實(shí)驗(yàn)時(shí)間和降低測(cè)序成本。

BD Rhapsody單細(xì)胞分析系統(tǒng)可以定制靶向組合（panel），靶向方法有助于提高單細(xì)胞測(cè)序效率，并推動(dòng)對(duì)當(dāng)今一些挑戰(zhàn)性的科學(xué)領(lǐng)域的進(jìn)一步探索。BD經(jīng)驗(yàn)證的檢測(cè)試劑盒（panel）顯示穩(wěn)定且可重現(xiàn)的細(xì)胞異質(zhì)性陣列，可用于探索與眾多應(yīng)用相關(guān)的細(xì)胞類型。BD Rhapsody 系統(tǒng)包括以下檢測(cè)試劑盒（panel）：

□ BD Rhapsody Onco-BC 靶向檢測(cè)試劑盒（panel） – 與乳腺癌和免疫細(xì)胞相關(guān)的 400 個(gè)基因

□ BD Rhapsody 免疫反應(yīng)檢測(cè)試劑盒（panel） – 免疫細(xì)胞類型譜分析

□ BD Rhapsody  T-細(xì)胞靶向檢測(cè)試劑盒（panel）

□ BD Rhapsody 補(bǔ)充檢測(cè)試劑盒（panel）

□ BD Rhapsody 自定義檢測(cè)試劑盒（panel）

BD Rhapsody Onco-BC 靶向檢測(cè)試劑盒（panel）

Panel designed by scientists, for scientists

The customizable and validated BD Rhapsody Onco-BC Targeted Panel was created from collaborations with clinical oncologists.

The panel content combines data from experimental and database sources, chosen to include genes with known involvement in cancer progression, proliferation, epithelial-tomesenchymal transition (EMT) and cancer stem cells. Including PAM50 genes aids molecular subtyping of breast cancer cells¹,while immunophenotyping and stromal cell markers enable comprehensive surveys of the complex tumor microenvironment.

科學(xué)家為科學(xué)家設(shè)計(jì)的Panel

可定制且經(jīng)過驗(yàn)證的BD Rhapsody Onco-BC乳腺癌靶向Panel是由臨床腫瘤學(xué)家合作開發(fā)的。

BD Rhapsody Onco-BC乳腺癌靶向Panel結(jié)合了來自實(shí)驗(yàn)和數(shù)據(jù)庫來源的數(shù)據(jù)，選擇的數(shù)據(jù)包括已知參與癌癥progression，擴(kuò)增，上皮 - 間質(zhì)轉(zhuǎn)化（EMT）和癌癥干細(xì)胞的基因。 包括PAM50基因有助于乳腺癌細(xì)胞的分子亞型¹，而免疫分型和基質(zhì)細(xì)胞標(biāo)志物可以對(duì)復(fù)雜的腫瘤微環(huán)境進(jìn)行全面調(diào)查。

Tailored libraries for targeted sequencing

The BD Rhapsody Onco-BC Targeted Panel is designed for the BD Rhapsody system, and uses multiplex PCR for detecting up to 389 genes. After cells are lysed in the BD Rhapsody Cartridge,

beads hybridized with mRNA are magnetically retrieved for cDNA synthesis. Primers included in the BD Rhapsody Onco-BC Targeted Panel and BD Rhapsody Supplemental Panel are used for several rounds of gene-specific, nested PCR for library construction. Final PCR products for sequencing contain adapters, a cell label, a unique molecular index (UMI), and up to 400 bp of the 3’ end of a target gene. Assay products may be sequenced on Illumina® MiniSeq, MiSeq, NextSeq, HiSeq2500 and HiSeq4000 sequencers.

靶向測(cè)序的定制文庫

BD Rhapsody Onco-BC乳癌靶向Panel專為BD Rhapsody系統(tǒng)設(shè)計(jì)，使用多重PCR檢測(cè)多達(dá)389個(gè)基因。細(xì)胞在BD Rhapsody Cartridge中裂解后，與mRNA雜交的磁珠被磁性回收用于cDNA合成。包含在BD Rhapsody Onco-BC靶向Panel和BD Rhapsody Supplemental Panel 中的引物用于多輪基因特異性巢式PCR，用于構(gòu)建文庫。用于測(cè)序的zui終PCR產(chǎn)物含有接頭，細(xì)胞標(biāo)記（label），*的分子索引（unique molecular index，UMI）和3'末端高達(dá)400bp的靶基因。檢測(cè)產(chǎn)物可以在Illumina®MiniSeq，MiSeq，NextSeq，HiSeq2500和HiSeq4000測(cè)序儀上進(jìn)行測(cè)序。

Figure 1. cDNA synthesis and library construction chemistry with the BD Rhapsody Onco-BC Targeted Panel.

圖1.BD Rhapsody Onco-BC Targeted Panel的cDNA合成和文庫構(gòu)建原理

Your target genes, delivered your way

Researchers may select up to 100 additional genes for analysis,with the BD Rhapsody Supplemental Panel. Using BD’s primer design software, primers for supplemental gene targets are designed to be compatible with pre-designed base panels.

Supplemental primers are shipped to you and combined with the BD Rhapsody Onco-BC Targeted Panel for library preparation.

專屬目標(biāo)基因定制

研究人員可以經(jīng)由BD Rhapsody Supplemental Panel選擇zui多100個(gè)額外基因分析。使用BD的引物設(shè)計(jì)軟件，補(bǔ)充目標(biāo)基因的引物可以與預(yù)設(shè)基礎(chǔ)panel兼容。

Remarkable panel performance—single-cell suspensions from a metastatic breast cancer sample

In the following example, cryopreserved single-cell suspensions from a disaggregated metastatic breast cancer patient sample were sorted using the BD FACSAria™ system to enrich for live cells. 4,409 cells derived from a lymph node metastasis were profiled using the BD Rhapsody system. Fifteen cell types were detected, including four subpopulations of breast cancer cells and a diverse tumor microenvironment of stromal and major immune cell types. Because the analysis focused on just five percent of the transcriptome, the amount of sequencing is drastically lowered.

的panel性能—轉(zhuǎn)移性乳腺癌樣本的單細(xì)胞懸液

在下面的實(shí)例中，使用BD FACSAria ^TM系統(tǒng)分選來自disaggregated轉(zhuǎn)移性乳腺癌患者樣品的凍存單細(xì)胞懸浮液以富集活細(xì)胞。使用BD Rhapsody系統(tǒng)對(duì)來源于淋巴結(jié)轉(zhuǎn)移的4,409個(gè)細(xì)胞進(jìn)行分析。檢測(cè)到15種細(xì)胞類型，包括4種乳腺癌細(xì)胞亞群和多種腫瘤微環(huán)境（間質(zhì)細(xì)胞和主要免疫細(xì)胞組成）。由于分析只集中在轉(zhuǎn)錄組的5％，因此測(cè)序通量極大降低。

Table 1: Example genes by category

Pathway # of genes in panel

Cell adhesion 23；Cell cycle 44；Chemokine/chemokine receptor,cytokine/cytokine receptor 53；

Signal transduction 56；Oncogenes, tumor suppressors 10；Tumor immunity, immune checkpoint,

immune cell activation 24；Surface antigen 32；Other* 147（ Angiogenesis; cell death; complement system; structural; transport; DNA repair;epithelial-to-mesenchymal transition; hormone receptor; immunoglobulin; lncRNA;metabolism; multi-drug resistance; protease; transcription factor）

表1 參考基因

其他：血管生成; 細(xì)胞死亡; 補(bǔ)充體系;結(jié)構(gòu); 運(yùn)輸; DNA修復(fù);上皮間質(zhì)轉(zhuǎn)化; 激素受體;免疫球蛋白;lncRNA;代謝; 多重耐藥性;蛋白酶; 轉(zhuǎn)錄因子

表2：BD Rhapsody Onco-BC Targeted Panel metrics

BD Rhapsody Onco-BC乳癌靶向檢測(cè)panel應(yīng)用實(shí)例

轉(zhuǎn)移性乳腺癌樣本分析

Analysis of a metastatic breast cancer sample

Figure 2. Example data from analysis of a lymph node containing metastatic BrCa cells using the BD Rhapsody Onco-BC Targeted Panel. (a) tSNE projection of 4,409 cells annotated by cell type and (b) box plots of marker gene expression for each major cell type show complex tumor heterogeneity.

圖2.使用BD Rhapsody Onco-BC靶向Panel分析含有轉(zhuǎn)移性BrCa細(xì)胞淋巴結(jié)的實(shí)例數(shù)據(jù)。 （a）細(xì)胞類型注釋的4,409個(gè)細(xì)胞的tSNE projection和（b）每種主要細(xì)胞類型的標(biāo)志基因box plots顯示復(fù)雜的腫瘤異質(zhì)性。

Learn more about the power of targeted single-cell analysis

The BD Rhapsody Onco-BC Targeted Panel brings single-cell analysis within reach of all breast cancer researchers, by combining increased sequencing efficiency with a flexible approach to your projects. Contact us to find out how the BD Rhapsody panel can help you further the understanding of breast cancer biology.

了解更多單細(xì)胞靶向分析功能

BD Rhapsody Onco-BC Targeted Panel通過將更高的測(cè)序效率與靈活的方法結(jié)合到您的項(xiàng)目中，使所有乳腺癌研究人員都能夠進(jìn)行單細(xì)胞分析。，了解BD Rhapsodypanel如何幫助您進(jìn)一步了解乳腺癌生物學(xué)。

參考文獻(xiàn)

1. Parker JS, Mullins M, Cheang MCU, et al. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. Journal of Clinical Oncology. 2009;27(8):1160-1167.

歡迎您咨詢華雅再生醫(yī)學(xué)旗艦公司：紅榮微再（上海）生物工程技術(shù)有限公司  ：1500 1904 520。紅榮微再-客服:  經(jīng)銷商專員